Yakira Capital Management calls on Atrium Therapeutics to launch strategic review
RNA•Yakira Capital Management called on Atrium Therapeutics to launch a strategic review, curb cash spending and explain dilutive financing.
1. Yakira's requests
Yakira Capital Management called on Atrium Therapeutics to launch a strategic review, curb cash spending and explain dilutive financing.
